Literature DB >> 16425134

Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.

Michiaki Koga1, Michel Gilbert, Masaki Takahashi, Jianjun Li, Saiko Koike, Koichi Hirata, Nobuhiro Yuki.   

Abstract

BACKGROUND: Guillain-Barre syndrome (GBS), a postinfectious autoimmune-mediated neuropathy, is a serious complication after Campylobacter jejuni enteritis.
METHODS: To investigate the bacterial risk factors for developing GBS, genotypes, serotypes, and ganglioside mimics on lipo-oligosaccharide (LOS) were analyzed in C. jejuni strains from Japanese patients.
RESULTS: Strains from patients with GBS had LOS biosynthesis locus class A more frequently (72/106; 68%) than did strains from patients with enteritis (17/103; 17%). Class A strains predominantly were serotype HS:19 and had the cstII (Thr51) genotype; the latter is responsible for biosynthesis of GM1-like and GD1a-like LOSs. Both anti-GM1 and anti-GD1a monoclonal antibodies regularly bound to class A LOSs, whereas no or either antibody bound to other LOS locus classes. Mass-spectrometric analysis showed that a class A strain carried GD1a-like LOS as well as GM1-like LOS. Logistic regression analysis showed that serotype HS:19 and the class A locus were predictive of the development of GBS.
CONCLUSIONS: The high frequency of the class A locus in GBS-associated strains, which was recently reported in Europe, provides the first GBS-related C. jejuni characteristic that is common to strains from Asia and Europe. The class A locus and serotype HS:19 seem to be linked to cstII polymorphism, resulting in promotion of both GM1-like and GD1a-like structure synthesis on LOS and, consequently, an increase in the risk of producing antiganglioside autoantibodies and developing GBS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425134     DOI: 10.1086/499969

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

Review 1.  Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination.

Authors:  Eitan Israeli; Nancy Agmon-Levin; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

2.  GQ1b-seronegative Fisher syndrome: clinical features and new serological markers.

Authors:  Michiaki Koga; Michel Gilbert; Masaki Takahashi; Jianjun Li; Koichi Hirata; Takashi Kanda; Nobuhiro Yuki
Journal:  J Neurol       Date:  2012-01-05       Impact factor: 4.849

3.  Evaluation of the Diagnostic Accuracy of Two Immunochromatographic Tests Detecting Campylobacter in Stools and Their Role in Campylobacter Infection Diagnosis.

Authors:  Emilie Bessède; Julien Asselineau; Paul Perez; Guillaume Valdenaire; Olivier Richer; Philippe Lehours; Francis Mégraud
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

4.  Interaction of Copper Toxicity and Oxidative Stress in Campylobacter jejuni.

Authors:  Susan P Gardner; Jonathan W Olson
Journal:  J Bacteriol       Date:  2018-10-10       Impact factor: 3.490

5.  Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.

Authors:  Michiaki Koga; Masaki Takahashi; Keiko Yokoyama; Takashi Kanda
Journal:  J Neurol       Date:  2015-06-09       Impact factor: 4.849

6.  Selective biochemical labeling of Campylobacter jejuni cell-surface glycoconjugates.

Authors:  Garrett E Whitworth; Barbara Imperiali
Journal:  Glycobiology       Date:  2015-03-11       Impact factor: 4.313

7.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

8.  Host factors determine anti-GM1 response following oral challenge of chickens with Guillain-Barré syndrome derived Campylobacter jejuni strain GB11.

Authors:  C Wim Ang; Jeroen R Dijkstra; Marcel A de Klerk; Hubert Ph Endtz; Pieter A van Doorn; Bart C Jacobs; Suzan H M Jeurissen; Jaap A Wagenaar
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

9.  Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh.

Authors:  Zhahirul Islam; Alex van Belkum; Jaap A Wagenaar; Alison J Cody; Albert G de Boer; Helen Tabor; Bart C Jacobs; Kaisar A Talukder; Hubert P Endtz
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

10.  Campylobacter jejuni HS:23 and Guillain-Barre syndrome, Bangladesh.

Authors:  Zhahirul Islam; Alex van Belkum; Alison J Cody; Helen Tabor; Bart C Jacobs; Kaisar A Talukder; Hubert P Endtz
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.